Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous bone marrow derived mesenchymal cells (1 trial)
Spinal Cord Injuries (Phase 2)
Wounds and Injuries (Phase 2)
Trials (1 total)
Trial APIs (1 total)